Soft pastels · Free shipping over $75 · Shop the boutique
Login Register
glp-1 alzheimer's study

glp-1 alzheimer's study improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in disease Weight-Loss Drugs May Reduce Buildup

SKU: 96046764976

4.0
USD27.02 USD52.02

Pay in 4 interest-free payments of $6.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

10.1126/scitranslmed.aal2658 90

glp-1 alzheimer's study improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in disease Weight-Loss Drugs May Reduce Buildup

In addition to lowering blood glucose levels to help treat type 2 diabetes, GLP-1 agonists also result in weight loss and other metabolic health benefits

glp-1 alzheimer's study improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in disease Weight-Loss Drugs May Reduce Buildup

Research focuses on mechanistic behavior under controlled conditions rather than applications involving growth factors or enhancement

glp-1 alzheimer's study improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in disease Weight-Loss Drugs May Reduce Buildup

doi: 10.1615/intjmedmushrooms.v17.i7.10

glp-1 alzheimer's study improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in disease Weight-Loss Drugs May Reduce Buildup
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products